Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,019 | 2,812 | 3,498 | 5,032 | 5,079 |
| Receivables | 6,206 | 5,006 | 5,078 | 4,830 | 5,529 |
| Other current assets | 1,941 | 1,598 | 1,841 | 1,576 | 2,367 |
| TOTAL | $10,166 | $9,416 | $10,417 | $11,438 | $12,975 |
| Non-Current Assets | |||||
| PPE Net | 1,126 | 925 | 790 | 762 | 606 |
| Intangibles | 0 | 0 | 0 | 27 | 226 |
| Other Non-Current Assets | 1,680 | 1,801 | 1,909 | 2,023 | 2,135 |
| TOTAL | $2,806 | $2,726 | $2,699 | $2,812 | $2,967 |
| Total Assets | $12,972 | $12,142 | $13,116 | $14,250 | $15,942 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,500 |
| Accounts payable and accrued liabilities | 1,761 | 1,363 | 1,544 | 1,352 | 1,689 |
| Accrued Expenses | 1,243 | 878 | 1,969 | 1,299 | 1,127 |
| TOTAL | $19,030 | $18,973 | $11,436 | $12,324 | $13,565 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,343 | 4,243 | 11,565 | 11,307 |
| Other Non-Current Liabilities | 52,968 | 52,967 | 52,976 | 53,041 | 53,276 |
| TOTAL | $52,968 | $54,310 | $57,219 | $64,606 | $64,583 |
| Total Liabilities | $71,998 | $73,283 | $68,655 | $76,930 | $78,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,394 | 4,376 | 4,376 | 4,322 | 4,314 |
| Common Shares | 406 | 406 | 405 | 405 | 405 |
| Retained earnings | -245,685 | -247,747 | -242,082 | -249,105 | -248,491 |
| Other shareholders' equity | -24 | -24 | -8 | 3 | 15 |
| TOTAL | $-59,026 | $-61,141 | $-55,539 | $-62,680 | $-62,206 |
| Total Liabilities And Equity | $12,972 | $12,142 | $13,116 | $14,250 | $15,942 |